Featured post
SCS research and awards news
For all our research and awards news, please visit our news page.
Monday, 5 June 2017
Reliability of noncontrast-enhancing tumor as a biomarker of IDH1 mutation status in glioblastoma.
Stephen Stuckey
et al
. published in the
Journal of Clinical Neuroscience.
Read article
here
.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment